ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1615

Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

Fatih Yildirim1, Cemal Bes2, Muhammet Emin Kutu3, Fatih Tastekin4, Gokhan Keser5, Tugba Ocak6, Ediz Dalkilic6, Yavuz Pehlivan6, Hasan Kocaayan7, Servet Akar7, Sema İsik8, Ahmet Omma9, Senar San10, Ayten Yazici11, Ayse Cefle11, Safiye Bakkal12, Gökçe Kenar13, Fatos Onen12, Aysegül Avcu14, Fatma Alibaz Öner15, Haner Direskeneli15, Burcu Ceren Uludogan16, Nazife Sule yaşar Bile16 and Nilüfer Alpay Kanıtez17, 1University of Health Sciences Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey, İstanbul, Turkey, 2University of Health Sciences Başakşehir Çam and Sakura City HospitalUniversity of Health Sciences Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey, İstanbul, Turkey, 3Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey, 4Ege University School of Medicine, Rheumatology, İzmir, Turkey, İzmir, Turkey, 5Ege University School of Medicine, Rheumatology, İzmir, Turkey, Izmir, Turkey, 6Uludağ University Faculty of Medicine, Rheumatology, Bursa, Turkey, Bursa, Turkey, 7İzmir Katip Celebi University School of Medicine, Rheumatology, İzmir, Turkey, İzmir, Turkey, 8University of Health Sciences Ankara Bilkent City Hospital, Rheumatology, Ankara, Turkey, Ankara, Turkey, 9Ankara Bilkent City Hospital, Ankara, Turkey, 10Kocaeli University Faculty of Medicine, Rheumatology, Kocaeli, Turkey, Kocaeli, Turkey, 11Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Kocaeli, Turkey, 12Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, İzmir, Turkey, 13Dokuz Eylul University School of Medicine, Izmir, Turkey, 14Marmara University Faculty of Medicine, Rheumatology, İstanbul, Turkey, İstanbul, Turkey, 15Marmara University Faculty of Medicine, Rheumatology, İstanbul, Turkey, Istanbul, Turkey, 16Osmangazi University Faculty of Medicine, Rheumatology, Eskişehir, Turkey, Eskisehir, Turkey, 17Koc University Faculty of Medicine, Rheumatology, İstanbul, Turkey, Istanbul, Turkey

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Disease Activity, Imaging, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The understanding of progression or minimal disease activity in patients with Takayasu arteritis (TA) can be complicated due to the possibility of mild vascular inflammation without clinical signs and ongoing vascular fibrosis independent of disease activity. EULAR recommends based on clinical findings, while ACR directly recommends regularly scheduled noninvasive imaging in addition to routine clinical assessment. However, the literature regarding the impact of regular imaging in clinical practice is limited. The aim of this study is to understand the relationship of imaging decisions with clinical activity and their impact on clinical practice in the follow-up of TA patients.

Methods: A total of 204 adult patients with TA who followed up in 11 tertiary centers in Turkey were included in this study. All patients met the 1990 ACR Takayasu arteritis diagnostic criteria. These centers applied their preferences regarding the frequency of screening as well as the imaging method in follow-up. All imaging, clinical, and laboratory findings of the patients were obtained retrospectively from outpatient files. At each imaging visit, disease activity status and whether treatment changes were made were recorded. It was designed as a retrospective study.

Results: The median age of the patients was 44 (33-56) years, the median follow-up time was 6 years, and 177 (86,8%) of them were women (Table 1). A total of 580 imaging modalities were recorded for 204 patients. The most preferred imaging modalities by clinicians were MR angiography (37.5%) and CT angiography (32.2%). Progression and/or activity was found in 116 (20%) of a total of 580 imaging. It was observed that treatment changes were made in 236 (41%) of the visits. The physician’s global assessment (PGA) and the presence of radiological progression or activity were independent factors for treatment change (Table 2). It was found that 418 (72%) of the images were performed while PGA was inactive (Table 3). Radiological progression and/or activity was detected in only 18 (4%) of the PGA inactive imaging.

Conclusion: PGA and radiological progression and/or activity are the main determinants of treatment decisions in TA. However, there were no progression as well as activity in the imaging applied in the majority of patients. Moreover, in patients thought to be clinically inactive, radiological findings were often not significant enough to change treatment. In the follow-up of patients with TA, performing imaging on an individual basis may alleviate the workload, prevent additional radiation exposure, and be more cost-effective compared to applying regularly scheduled imaging. Analyzes regarding the effect of regularly scheduled imaging on the damage outcomes are ongoing.

Supporting image 1

Table 1: Comparative data according to radiological signs

Supporting image 2

Table 2: Multivariate analysis of predictors for treatment changes

Supporting image 3

Table 3: Distribution of imaging modalities according to PGA


Disclosures: F. Yildirim: None; C. Bes: None; M. Kutu: None; F. Tastekin: None; G. Keser: None; T. Ocak: None; E. Dalkilic: None; Y. Pehlivan: None; H. Kocaayan: None; S. Akar: None; S. İsik: None; A. Omma: None; S. San: None; A. Yazici: None; A. Cefle: None; S. Bakkal: None; G. Kenar: None; F. Onen: None; A. Avcu: None; F. Alibaz Öner: AbbVie/Abbott, 12, Educational grants, Amgen, 12, Educational grants, Roche, 12, Educational grants, UCB, 12, Educational grants; H. Direskeneli: AbbVie/Abbott, 12, Educational grants, Amgen, 12, Educational grants, Roche, 12, Educational grants, UCB, 12, Educational grants; B. Uludogan: None; N. yaşar Bile: None; N. Alpay Kanıtez: None.

To cite this abstract in AMA style:

Yildirim F, Bes C, Kutu M, Tastekin F, Keser G, Ocak T, Dalkilic E, Pehlivan Y, Kocaayan H, Akar S, İsik S, Omma A, San S, Yazici A, Cefle A, Bakkal S, Kenar G, Onen F, Avcu A, Alibaz Öner F, Direskeneli H, Uludogan B, yaşar Bile N, Alpay Kanıtez N. Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/is-regular-vascular-imaging-scheduled-essential-in-the-follow-up-of-takayasu-arteritis-a-large-scale-multicenter-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-regular-vascular-imaging-scheduled-essential-in-the-follow-up-of-takayasu-arteritis-a-large-scale-multicenter-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology